Perinatal Depression and Adverse Childhood Experiences: Prevention Trial

Running, not enrolling · Not applicable

Conditions studied: Perinatal Depression

In brief

The goal of this clinical trial is to evaluate the impact of ROSE in individuals with adverse childhood experiences. The main question it aims to answer is, compared to enhanced treatment as usual, does the delivery of ROSE within a collaborative care model improve depressive symptom trajectories and prevent the development of perinatal depression. Participants will be randomized to either enhanced treatment as usual or the ROSE intervention, delivered by a care manager within a perinatal collaborative care program. They will complete self-reported surveys of their depression symptoms every 4 weeks to inform their symptom trajectories. They will also complete clinical interviews to establish any incident diagnoses of a major depressive episode.

Key facts

Study ID

NCT05795114

Run by

Northwestern University

People needed

76

Starts

2023-07-20

Expected to finish

2026-10-31

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• At least one prenatal visit at Northwestern Medicine
• Less than 24 weeks gestation
• Non-anomalous pregnancy
• English- or Spanish- speaking
• ACE score ≥ 2
• Singleton gestation

You may not qualify if…

• Intent to delivery outside of Prentice Women's Hospital
• Active major depressive episode
• Active substance use disorder
• Participation in a study with a competing intervention or outcome

Where it is running

• Northwestern Medicine — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.